Bottom line
LOGSX vs IYH: the short answer
LOGSX (Live Oak Health Sciences Fund) and IYH (iShares U.S. Healthcare ETF) are both mutual funds.
But IYH is far broader, holding 103 positions to 28 for LOGSX, so beyond the top names it adds exposure LOGSX doesn't have.
IYH is cheaper at 0.37% vs 1.04% — a difference of $67 a year per $10,000 invested.
Over five years, LOGSX returned +8.1% a year vs +7.0% for IYH.
Updated Nov 19, 2026
LOGSX vs IYH side by side
| LOGSX | IYH | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Oak Associates | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.04% | 0.37% |
| Annual cost per $10k | $104 | $37 |
| 10-yr cost on $10k (prospectus) | $1,271 | $468 |
| Max front load | — | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +19.6% | +13.1% |
| 5-yr return (annualized) | +8.1% | +7.0% |
| 10-yr return (annualized) | +7.3% | +9.4% |
| Best quarter | +13.4% | +15.3% |
| Worst quarter | −13.1% | −12.7% |
| Net assets (fund) | $56.1M | $3.6B |
| Number of holdings | 28 | 103 |
| Portfolio turnover | 24% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | LOGSX | IYH | Difference |
|---|---|---|---|
| 2025 | +19.6% | +13.1% | +6.5% |
| 2024 | +0.2% | +3.1% | −2.9% |
| 2023 | +1.2% | +2.1% | −0.9% |
| 2022 | +3.7% | −4.4% | +8.1% |
| 2021 | +17.5% | +23.4% | −5.9% |
| 2020 | +6.0% | +15.5% | −9.5% |
| 2019 | +19.0% | +20.8% | −1.8% |
| 2018 | −4.0% | +5.9% | −9.8% |
| 2017 | +13.4% | +22.3% | −8.9% |
| 2016 | −0.4% | −2.8% | +2.4% |
Source: Fund prospectus bar charts
Holdings overlap
11 of LOGSX's top 25 holdings also appear in IYH's top 25.
| Holding | LOGSX | IYH |
|---|---|---|
| Amgen Inc | 4.86% | 3.42% |
| Regeneron Pharmaceuticals Inc | 4.43% | 1.27% |
| Bristol-myers Squibb Company | 4.02% | 2.20% |
| Johnson & Johnson | 3.77% | 10.17% |
| Gilead Sciences Inc | 3.50% | 2.66% |
| Cigna Group (the) | 3.46% | 1.20% |
| Vertex Pharmaceuticals Inc | 3.26% | 2.00% |
| Merck & Company Inc | 3.16% | 5.31% |
| Medtronic Plc | 3.01% | 1.80% |
| Intuitive Surgical Inc | 2.99% | 2.05% |
| Eli Lilly & Company | 1.99% | 15.11% |
Source: SEC Form N-PORT
LOGSX top 10
- N/a — 6.91%
- Cardinal Health Inc — 5.86%
- Jazz Pharmaceuticals Plc — 5.77%
- United Therapeutics Corp — 5.11%
- Exelixis Inc — 4.95%
- Amgen Inc — 4.86%
- Lantheus Holdings Inc — 4.68%
- Novartis Ag — 4.67%
- Mckesson Corp — 4.53%
- Cencora Inc — 4.46%
IYH top 10
- Eli Lilly And Company — 15.11%
- Johnson & Johnson — 10.17%
- Abbvie Inc. — 7.32%
- Unitedhealth Group Incorporated — 6.16%
- Merck & Co., Inc. — 5.31%
- Thermo Fisher Scientific Incorporated — 3.52%
- Amgen Inc. — 3.42%
- Abbott Laboratories — 3.02%
- Gilead Sciences, Inc. — 2.66%
- Pfizer Inc. — 2.35%
FAQ
What is the difference between LOGSX and IYH?
Which is cheaper, LOGSX or IYH?
Should I own both LOGSX and IYH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.